Search Results - "Banks, P L"

Cytarabine Plus Idarubicin or Daunorubicin as Induction and Consolidation Therapy for Previously Untreated Adult Patients With Acute Myeloid Leukemia by Wiernik, Peter H., Banks, Phillip L.C., Case, Delvyn C., Arlin, Zalmen A., Periman, Phillip O., Todd, Mary B., Ritch, Paul S., Enck, Robert E., Weitberg, Alan B.

“…The purpose of this study was to determine the relative merits of idarubicin and daunorubicin in acute myeloid leukemia (AML) therapy. Thirty-two sites…”
Get full text

Select dietary fatty acids attenuate cardiopulmonary dysfunction during acute lung injury in pigs by Murray, M J, Kumar, M, Gregory, T J, Banks, P L, Tazelaar, H D, DeMichele, S J

“…We examined the effect of substituting linoleic acid (LA) with eicosapentaenoic acid (EPA) and gamma-linolenic acid (gamma-LA), precursors of trienoic and…”
Get full text

Rapid modulation of lung and liver macrophage phospholipid fatty acids in endotoxemic rats by continuous enteral feeding with n-3 and gamma-linolenic fatty acids by Palombo, JD, DeMichele, SJ, Lydon, EE, Gregory, TJ, Banks, PL, Forse, RA, Bistrian, BR

“…Dienoic eicosanoids derived from phospholipid arachidonic acid (AA) in lung and liver macrophages promote leukosequestration, thrombosis, and tissue injury…”
Get full text

A phase III trial comparing idarubicin and daunorubicin in combination with cytarabine in acute myelogenous leukemia: a Southeastern Cancer Study Group Study by Vogler, W R, Velez-Garcia, E, Weiner, R S, Flaum, M A, Bartolucci, A A, Omura, G A, Gerber, M C, Banks, P L

“…A randomized clinical trial was undertaken to compare the therapeutic effectiveness of idarubicin (IDR) to daunorubicin (DNR), and both were given in…”
Get more information

Surfactant therapy and intracranial hemorrhage : review of the literature and results of new analyses by GUNKEL, J. H, BANKS, P. L. C

“…Surfactant replacement is a powerful therapy for newborns with respiratory distress syndrome, but limited observations suggest that alterations of cerebral…”
Get full text

Cytarabine plus idarubicin or daunorubicin as induction and consolidation therapy for previously untreated adult patients with acute myeloid leukemia by Wiernik, PH, Banks, PL, Case, DC Jr, Arlin, ZA, Periman, PO, Todd, MB, Ritch, PS, Enck, RE, Weitberg, AB

“…The purpose of this study was to determine the relative merits of idarubicin and daunorubicin in acute myeloid leukemia (AML) therapy. Thirty-two sites…”
Get full text